Oncology Companion Diagnostics Xchange West Coast

Join Flagship for the Oncology Companion Diagnostics Xchange at hubXchange West

February 6-9, 2023

Attending hubXchange West? Meet with us to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program.

AI-powered digital pathology solutions
Immuno-oncology biomarker development and validation
Spatial biology and molecular diagnostics analysis
Immunotherapy clinical trial support
CDx development
Regulatory guidance

Tom Turi, Ph.D.

Chief Scientific Officer at
Flagship Biosciences
presents

Opening Address & Keynote Presentation

Wednesday, February 9 at 8:30 am PST

Spatial Biology to Improve Clinical Trial Outcomes

Increasing accuracy and yield of existing
biomarker assays
Investigating spatial and image analysis solutions
for patient selection
Expanding the use of spatial imaging applications
beyond oncology

Clinical Biomarkers Track

Wednesday, February 9 at 11:20 PST

Challenges / Barriers to broader adoption of spatial biology analysis techniques

Testing technology options
What are the limits to integrating spatial platforms
Challenges with integrated data analysis

The Digital Pathology Advantage

Improve ROI, accelerate trials, and minimize budget impacts
Minimize recruitment costs and other clinical trial expenses
Discover cost benefits of Flagship’s image analysis platform

See the guide >>

Driving Your Biomarker Strategy: Facts by numbers

View our resume and history to learn why Flagship is the premier partner for your study
See the full list of spatial biology services that empower confident clinical decision making
See the benefits with a fully integrated team of scientists and pathologists

Download the facts >>